Delaware
|
0-10783
|
75-1590407
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01
|
Regulation
FD Disclosure.
|
Item
9.01.
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits
|
99.1
|
Press
Release of BSD Medical Corporation dated April 24,
2008
|
Dated: April
24, 2008
|
||
By:
|
/s/ Hyrum
A.
Mead
|
|
Hyrum
A. Mead
|
||
President
|
||